Notably, FLT3-ITD is linked to a deleterious prognosis, with a high FLT3-ITD allelic ratio indicating a particularly poor outcome in pediatric AML patients [9], and research on FLT3-TKD mutations shows inconsistent prognostic implications [6,10]. The gene discussed is FLT3; the disease is acute myeloid leukemia.